Literature DB >> 21764261

Practitioner perceptions of attenuated psychosis syndrome.

Elizabeth Jacobs1, Emily Kline, Jason Schiffman.   

Abstract

The "Attenuated Psychosis Syndrome" (APS, sometimes referred to as the "schizophrenia prodrome") is characterized by subthreshold psychotic-like symptoms and functional decline, and is often associated with significant disability. These symptoms may cause impairment and are of further interest due to their predictive relation to schizophrenia and other psychotic disorders. These symptoms currently are not represented in the diagnostic system for mental health, and it is unclear how they are conceptualized by relevant professionals. The current study surveyed a national sample (n=303) of clinical psychologists, psychiatrists, and general practitioners regarding their clinical appraisal of APS. Practitioners were asked to respond to vignettes representing three conditions: psychosis, subthreshold psychosis (indicating 'attenuated' psychosis symptoms), and no psychotic symptoms. Practitioners' responses suggested that APS is viewed consistently with a DSM-IV-TR defined mental disorder and that most clinicians may diagnose this condition as a full threshold psychotic disorder. Findings tentatively suggest that the inclusion of an attenuated psychosis symptoms category in the forthcoming DSM-5 may be helpful in improving diagnostic reliability and facilitating best practice among community practitioners.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21764261      PMCID: PMC3717257          DOI: 10.1016/j.schres.2011.06.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  31 in total

1.  The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies.

Authors:  H Häfner; W an der Heiden
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

Review 2.  Practice guideline for the treatment of patients with schizophrenia, second edition.

Authors:  Anthony F Lehman; Jeffrey A Lieberman; Lisa B Dixon; Thomas H McGlashan; Alexander L Miller; Diana O Perkins; Julie Kreyenbuhl
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

3.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

4.  Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.

Authors:  Anthony P Morrison; Paul French; Sophie Parker; Morwenna Roberts; Helen Stevens; Richard P Bentall; Shôn W Lewis
Journal:  Schizophr Bull       Date:  2006-09-14       Impact factor: 9.306

5.  The psychosis threshold in Ultra High Risk (prodromal) research: is it valid?

Authors:  Alison R Yung; Barnaby Nelson; Andrew Thompson; Stephen J Wood
Journal:  Schizophr Res       Date:  2010-04-08       Impact factor: 4.939

6.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

7.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

Review 8.  Intervention in individuals at ultra-high risk for psychosis: a review and future directions.

Authors:  Patrick D McGorry; Barnaby Nelson; G Paul Amminger; Andreas Bechdolf; Shona M Francey; Gregor Berger; Anita Riecher-Rössler; Joachim Klosterkötter; Stephan Ruhrmann; Frauke Schultze-Lutter; Merete Nordentoft; Ian Hickie; Philip McGuire; Michael Berk; Eric Y H Chen; Matcheri S Keshavan; Alison R Yung
Journal:  J Clin Psychiatry       Date:  2009-06-30       Impact factor: 4.384

9.  Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.

Authors:  Michael T Compton; Mary E Kelley; Claire E Ramsay; Makenya Pringle; Sandra M Goulding; Michelle L Esterberg; Tarianna Stewart; Elaine F Walker
Journal:  Am J Psychiatry       Date:  2009-10-01       Impact factor: 18.112

10.  Anticipating DSM-V: should psychosis risk become a diagnostic class?

Authors:  William T Carpenter
Journal:  Schizophr Bull       Date:  2009-07-24       Impact factor: 9.306

View more
  7 in total

1.  Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic.

Authors:  Brandon A Gaudiano; Mark Zimmerman
Journal:  J Clin Psychiatry       Date:  2012-10-02       Impact factor: 4.384

2.  Considerations for the development and implementation of brief screening tools in the identification of early psychosis.

Authors:  Jason Schiffman
Journal:  Schizophr Res       Date:  2018-03-07       Impact factor: 4.939

3.  Evaluating the tendencies of community practitioners who actively practice in child and adolescent psychiatry to diagnose and treat DSM-5 attenuated psychotic syndrome.

Authors:  Helin Yilmaz Kafali; Mireia Solerdelcoll; Lena Vujinovic; Dmytro Martsenkovskyi; Sewanu Awhangansi; Camille Noel; Emre Bora; Celso Arango
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-10-20       Impact factor: 5.349

4.  Defining treatment as usual for attenuated psychosis syndrome: a survey of community practitioners.

Authors:  Elizabeth Jacobs; Emily Kline; Jason Schiffman
Journal:  Psychiatr Serv       Date:  2012-12       Impact factor: 3.084

5.  Attenuated psychosis syndrome: benefits of explicit recognition.

Authors:  Jason Schiffman; William T Carpenter
Journal:  Shanghai Arch Psychiatry       Date:  2015-02-25

6.  Social work training to reduce duration of untreated psychosis: Methodology and considerations of a web-based training for community providers.

Authors:  Nicole D Andorko; John Fitzgerald; Caroline Roemer; Eric Solender; Emily Petti; Pamela Rakhshan Rouhakhtar; Karen E McNamara; Melissa E Smith; Robert W Buchanan; Jason Schiffman; Jordan DeVylder
Journal:  Early Interv Psychiatry       Date:  2021-05-24       Impact factor: 2.732

7.  School Counselors' Recognition of the Ultra-High Risk for Psychosis.

Authors:  Ju-Yeon Lee; Young-Chul Chung; Jae-Min Kim; Il-Seon Shin; Jin-Sang Yoon; Sung-Wan Kim
Journal:  Psychiatry Investig       Date:  2018-02-22       Impact factor: 2.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.